Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis gets German OK for swine flu vaccine

November 5, 2009
Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …

News

New Merck & Co opens for business

November 5, 2009
Sales and Marketing MA, Merck, restructure

The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …

News
Pfizer's Real Danger campaign

Digital Pharma: Pfizer’s multi-media dead rat

November 4, 2009
Medical Communications Pfizer, counterfeits, digi, get real

Pfizer has given a multi-media boost to its hard-hitting ‘dead rat’ campaign, which warns about the dangers of buying counterfeit …

Feature
Actelion Robin

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009
Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …

Appointment

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

News

DSM looking for new Chinese ingredient partners

November 4, 2009
Manufacturing and Production CMO, DSM

Dutch fine chemicals company DSM has said it will look for new partners in China after dissolving a joint venture …

News
Univar Michael

Univar Europe appoints Michael Cooke

November 3, 2009
Manufacturing and Production appointment, manufacturing and production, univar

Univar Europe has strengthened its pharma team with the appointment of Michael Cooke.Cooke, who was previously Univar’s director of safety, …

Appointment

Dr John Nash, Senior Director ADME/PK, BioFocus

November 3, 2009
Research and Development appointment, biofocus, research and development

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.  John has …

Appointment

Phase III success for GSK’s lupus drug

November 3, 2009
Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

News

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009
Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …

Feature

Fast times at contract research firm PPD

November 3, 2009
Research and Development CRO

Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …

News

UK lung cancer patients face ‘unacceptable postcode lottery’

November 3, 2009
NHS

Lung cancer patients in the UK face an "unacceptable postcode lottery", according to the first national review of lung cancer …

News

GSK-Genmab blood cancer drug approved in US

November 2, 2009
Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …

News

Lonza cuts staff, issues profits warning

November 2, 2009
Manufacturing and Production CMO

Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …

News
Synovate Jackie

Jackie Ilacqua, head of oncology, Synovate

November 2, 2009
Sales and Marketing appointment, sales and marketing, synovate

Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …

Appointment

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009
Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

News

GSK returns to growth despite US sales hit

October 28, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …

News

GSK begins phase III COPD trials

October 28, 2009
Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …

News
Tarceva tablets

Comparing notes: UK’s cancer leaders discuss the latest advances

October 28, 2009
Research and Development, Sales and Marketing Cancer

 

Feature
Ipsen Claude

Claude Bertrand joins Ipsen as Chief Scientific Officer

October 27, 2009
Research and Development appointment, ipsen, research and development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026